Wallace BK, Su ZT, Flynn JP, Garman TS, Weitzner A, Rezaee ME, et al. National trends in diagnoses of subtype histologies in bladder cancer: A population-based study based on the SEER database. Urol ...
The 2025 Western Section AUA annual meeting featured a kidney cancer session and a presentation by Jaxson Jeffery discussing the impact of neoadjuvant systemic therapy on tumor and tumor thrombus ...
Patients with low-grade upper tract urothelial carcinoma who achieved a complete response after receiving treatment with ...
Dr. Lee concluded his presentation discussing the comparative performance of UNFOLD AI, PSMA-PET, and mpMRI for prostate ...
Patients with bone-protecting agent use versus no bone-protecting agent had similar baseline characteristics: ...
The first 24 patients who received treatment with cretostimogene and were evaluated for high-grade recurrence-free survival and safety were evaluated. Kaplan-Meier estimates at 3- and 9-month ...
As of September 2025, 15 patients have been recruited across 8 centers. Spain, Belgium, and Ireland, with 15 centers, will be open for inclusion in Q4 of 2025, with 9 more centers in France also being ...
In patients with mHSPC, darolutamide consistently showed high efficacy, a similar incidence of treatment emergent adverse events to placebo, with similar or numerically lower treatment discontinuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback